BST-236
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BST-236, covering 2023-03-09 to 2025-05-18. Get the full timeline:
Most recent: Clinical Trial Update: BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS [Phase 2]